These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2112540)

  • 1. Single oral dose pharmacokinetics of the two main components of pristinamycin in humans.
    Koechlin C; Kempf JF; Jehl F; Monteil H
    J Antimicrob Chemother; 1990 Apr; 25(4):651-6. PubMed ID: 2112540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation
    Shan W; Peng F; Shen Q; Zhang J
    Drug Dev Ind Pharm; 2023 Jan; 49(1):84-91. PubMed ID: 36803496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity against Staphylococcus aureus of semisynthetic injectable streptogramins: RP 59500 and related compounds.
    Barrière JC; Bouanchaud DH; Paris JM; Rolin O; Harris NV; Smith C
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():1-8. PubMed ID: 1399940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of PIA and PIIA, the two main components of pristinamycin, by high-performance liquid chromatography in plasma.
    Koechlin C; Jehl F; Monteil H
    J Chromatogr; 1988 Mar; 425(1):197-202. PubMed ID: 3129442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on pristinamycin synergism in Staphylococcus aureus.
    Lacroix P; Aumercier M; Capmau ML; Le Goffic F
    J Antibiot (Tokyo); 1986 Sep; 39(9):1314-21. PubMed ID: 3096929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans.
    Bergeron M; Montay G
    J Antimicrob Chemother; 1997 May; 39 Suppl A():129-38. PubMed ID: 9511077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of quinupristin/dalfopristin.
    Bearden DT
    Clin Pharmacokinet; 2004; 43(4):239-52. PubMed ID: 15005638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476).
    Bernard E; Bensoussan M; Bensoussan F; Etienne S; Cazenave I; Carsenti-Etesse E; Le Roux Y; Montay G; Dellamonica P
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):768-71. PubMed ID: 7843184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pristinamycin accumulation by Staphylococcus aureus.
    Lacroix P; Capmau ML; Le Goffic F
    J Antibiot (Tokyo); 1984 Oct; 37(10):1246-52. PubMed ID: 6438039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and analysis of structural genes from Streptomyces pristinaespiralis encoding enzymes involved in the conversion of pristinamycin IIB to pristinamycin IIA (PIIA): PIIA synthase and NADH:riboflavin 5'-phosphate oxidoreductase.
    Blanc V; Lagneaux D; Didier P; Gil P; Lacroix P; Crouzet J
    J Bacteriol; 1995 Sep; 177(18):5206-14. PubMed ID: 7665509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteria.
    Laforest H; Fourgeaud M; Richet H; Lagrange PH
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1094-6. PubMed ID: 3142342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of the two-enzyme system catalyzing the oxidation of the D-proline residue of pristinamycin IIB during the last step of pristinamycin IIA biosynthesis.
    Thibaut D; Ratet N; Bisch D; Faucher D; Debussche L; Blanche F
    J Bacteriol; 1995 Sep; 177(18):5199-205. PubMed ID: 7665508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible binding of pristinamycin IIA (streptogramin A) to ribosomes explains its "lasting damage" effect.
    Aumercier M; Bouhallab S; Capmau ML; Le Goffic F
    J Antibiot (Tokyo); 1986 Sep; 39(9):1322-8. PubMed ID: 3096930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP 59500: a proposed mechanism for its bactericidal activity.
    Aumercier M; Bouhallab S; Capmau ML; Le Goffic F
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():9-14. PubMed ID: 1399955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of in vitro activity of pristinamycin against Haemophilus influenzae].
    Dabernat H
    Pathol Biol (Paris); 1993 Sep; 41(7):641-6. PubMed ID: 8255616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.
    Ramis J; Mis R; Forn J; Torrent J; Gorina E; Jané F
    Eur J Drug Metab Pharmacokinet; 1991; 16(4):269-73. PubMed ID: 1823870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled study of pristinamycin versus oxacillin in staphylococcal infections ].
    Bastin R; Rapin M; Kernbaum S
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):473-5. PubMed ID: 6812003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure-activity relationship of semi-synthetic derivatives of the PIA component of pristinamycin].
    Paris JM; Rolin O; Corbet JP; Cotrel C; Bouanchaud DH
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):493-6. PubMed ID: 3937125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.